You are here

ECIS Wound Healing High-Throughput Assay

Award Information
Agency: Department of Defense
Branch: Army
Contract: W911NF-05-C-0017
Agency Tracking Number: A043-071-1724
Amount: $70,000.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: A04-071
Solicitation Number: 2004.3
Timeline
Solicitation Year: 2004
Award Year: 2005
Award Start Date (Proposal Award Date): 2004-12-07
Award End Date (Contract End Date): 2005-06-06
Small Business Information
P.O. Box 80010
Austin, TX 78708
United States
DUNS: 022552900
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: Yes
Principal Investigator
 Theresa Curtis
 Staff Scientist
 (607) 272-0002
 tcurtis@agavebio.com
Business Contact
 Noe Salazar
Title: President
Phone: (512) 671-1369
Email: nsalazar@agavebio.com
Research Institution
N/A
Abstract

Healing of a wound is a complex and protracted process of tissue repair and remodeling in response to injury. Understanding how the body repairs damaged tissue and what genes and biochemical factors influence the wound healing process will have tremendous impact on the treatment of chronic wounds and the regeneration of tissue and organ function after injury. To facilitate the discovery of genes and compounds that are involved in wound healing, Agave BioSystems will develop an in vitro cell based system that will allow high-throughput analysis of genes and chemical compounds that may have a therapeutic affect in wound healing. This high-throughput, in vitro, wound healing assay will utilize small interfering RNA to specifically interfere with the function of genes of interest and Electric Cell-Substrate Impedance Sensing (ECIS) to non-invasively monitor the kinetics of fibroblast and epithelial wound healing.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government